(MENAFN- The Peninsula) The Peninsula
Doha:Methods for safeguarding human subjects in biomedical research were discussed at the latest conference in Weill Cornell Medicine Qatar's (WCM-Q) Law and Medicine series.
Entitled ‘The Role of Data and Safety Monitoring Boards in Human Subject Research', the conference brought physicians, researchers and healthcare professionals together at WCM-Q to hear expert speakers from around the globe explaining the ethics and safeguards used when conducting studies on humans.
The expert speakers included Susan Ellenberg, professor of biostatistics at the University of Pennsylvania, who explained how statistical analysis and data can be used to monitor and maximise safety of participants in clinical trials. Zoe Doran, head of the clinical trials support group at Mahidol Oxford Tropical Medicine Research Unit in Bangkok, discussed the unique challenges posed when conducting multinational clinical trials in many different countries at the same time. She also listed the expectations of data and safety monitoring boards (DSMB) that oversee these multinational trials.
Also speaking at the event were, Dr. Shahrad Taheri, professor of medicine and assistant dean for clinical investigations at WCM-Q, and Dr. Ziyad Mahfoud, WCM-Q's associate professor of healthcare policy and research. The conference concluded with a panel discussion moderated by Dr. Sunanda Holmes, WCM-Q's deputy chief administrative officer & associate university counsel, and assistant professor of healthcare policy and research.
MENAFN2901201800630000ID1096400945
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.